Spero Therapeutics (SPRO) Change in Receivables (2016 - 2026)
Spero Therapeutics posted quarterly Change in Receivables of $16000.0 for Q1 2026, up 100.66% year-on-year from $7973.6 in Q1 2025, and up 101.02% on a QoQ basis from -$1.6 million in Q4 2025.
Spero Therapeutics (SPRO) has 11 years of Change in Receivables data on file, last reported at $16000.0 in Q1 2026.
- For the quarter ending Q1 2026, Change in Receivables rose 100.66% year-over-year to $16000.0; the trailing twelve-month figure through Mar 2026 stood at -$624000.0 (up 85.65% YoY), and the FY2025 full-year result was -$3.1 million, down 298.51% from the prior year.
- Change in Receivables for Q1 2026 stood at $16000.0, up from -$1.6 million in the prior quarter.
- Across five years, Change in Receivables topped out at $3.5 million in Q1 2024 and bottomed at -$2.4 million in Q1 2025.
- The 5-year median for Change in Receivables is -$283000.0 (2024), against an average of -$152176.5.
- The widest annual swing landed in 2023, when Change in Receivables sank 1202.29%; it then soared 733.22% in 2025.
- A 5-year view of Change in Receivables shows it stood at $131000.0 in 2022, then tumbled by 1202.29% to -$1.4 million in 2023, then soared by 126.94% to $389000.0 in 2024, then sank by 501.8% to -$1.6 million in 2025, then jumped by 101.02% to $16000.0 in 2026.
- The last three Change in Receivables figures came in at $16000.0 (Q1 2026), -$1.6 million (Q4 2025), and -$869000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 208,524.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -39.80 Mn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -1.20 Mn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 110.42 Mn |
| 10 | Spero Therapeutics | 162.39 Mn | 106.26 Mn | - | 16,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 16,000.00 |
| Mar 31, 2026 | 16,000.00 |
| Dec 31, 2025 | -1.56 Mn |
| Dec 31, 2025 | -1.56 Mn |
| Sep 30, 2025 | -869,000.00 |
| Sep 30, 2025 | -869,000.00 |
| Jun 30, 2025 | 1.79 Mn |
| Jun 30, 2025 | 1.79 Mn |
| Mar 31, 2025 | -2.42 Mn |
| Mar 31, 2025 | -2.42 Mn |
| Dec 31, 2024 | 389,000.00 |
| Dec 31, 2024 | 389,000.00 |
| Sep 30, 2024 | -2.04 Mn |
| Sep 30, 2024 | -2.04 Mn |
| Jun 30, 2024 | -283,000.00 |
| Jun 30, 2024 | -283,000.00 |
| Mar 31, 2024 | 3.47 Mn |
| Mar 31, 2024 | 3.47 Mn |
| Dec 31, 2023 | -1.44 Mn |
| Dec 31, 2023 | -1.44 Mn |
| Sep 30, 2023 | 901,000.00 |
| Sep 30, 2023 | 901,000.00 |
| Jun 30, 2023 | 223,000.00 |
| Jun 30, 2023 | 223,000.00 |
| Mar 31, 2023 | 781,000.00 |
| Mar 31, 2023 | 781,000.00 |
| Dec 31, 2022 | 131,000.00 |
| Dec 31, 2022 | 131,000.00 |
| Sep 30, 2022 | -624,000.00 |
| Sep 30, 2022 | -624,000.00 |
| Jun 30, 2022 | -393,000.00 |
| Jun 30, 2022 | -393,000.00 |
| Mar 31, 2022 | -661,000.00 |
| Mar 31, 2022 | -661,000.00 |
| Dec 31, 2021 | 38,000.00 |
| Dec 31, 2021 | 38,000.00 |
| Sep 30, 2021 | 391,000.00 |
| Sep 30, 2021 | 391,000.00 |
| Jun 30, 2021 | -6.70 Mn |
| Jun 30, 2021 | -6.70 Mn |
| Mar 31, 2021 | 3.22 Mn |
| Mar 31, 2021 | 3.22 Mn |
| Dec 31, 2020 | -1.74 Mn |
| Dec 31, 2020 | -1.74 Mn |
| Sep 30, 2020 | 3.04 Mn |
| Sep 30, 2020 | 3.04 Mn |
| Jun 30, 2020 | 1.31 Mn |
| Jun 30, 2020 | 1.31 Mn |
| Mar 31, 2020 | -5.04 Mn |
| Mar 31, 2020 | -5.04 Mn |
| Dec 31, 2019 | 2.75 Mn |
| Dec 31, 2019 | 2.75 Mn |
| Sep 30, 2019 | 2.94 Mn |
| Sep 30, 2019 | 2.94 Mn |
| Jun 30, 2019 | 1.62 Mn |
| Jun 30, 2019 | 1.62 Mn |
| Mar 31, 2019 | 80,000.00 |
| Mar 31, 2019 | 80,000.00 |
| Dec 31, 2018 | 44,000.00 |
| Dec 31, 2018 | 44,000.00 |
| Sep 30, 2018 | -462,000.00 |
| Sep 30, 2018 | -462,000.00 |
| Jun 30, 2018 | -425,000.00 |
| Jun 30, 2018 | -425,000.00 |
| Mar 31, 2018 | 208,000.00 |
| Mar 31, 2018 | 208,000.00 |
| Dec 31, 2017 | 474,000.00 |
| Dec 31, 2017 | 474,000.00 |
| Sep 30, 2017 | 309,000.00 |
| Sep 30, 2017 | 309,000.00 |
| Jun 30, 2017 | 114,000.00 |
| Jun 30, 2017 | 114,000.00 |
| Mar 31, 2017 | -190,000.00 |
| Mar 31, 2017 | -190,000.00 |
| Dec 31, 2016 | 304,000.00 |
| Dec 31, 2016 | 304,000.00 |